These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3349314)

  • 1. Hormonal manipulation in the treatment of pancreatic carcinoma.
    Greenway BA
    Br J Surg; 1988 Feb; 75(2):187. PubMed ID: 3349314
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocrine therapy in pancreatic carcinoma.
    Yamashita J; Abe M; Ogawa M
    Oncology; 1998 Dec; 55 Suppl 1():17-22. PubMed ID: 9852398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of salivary gland hormones on pancreatic diseases].
    Shoji T; Onodera K; Kobiyama M
    Horumon To Rinsho; 1968 May; 16(5):389-96. PubMed ID: 5749427
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormonal manipulation for pancreatic carcinoma.
    Crowson MC; Fielding JW
    Br J Surg; 1987 Nov; 74(11):1067. PubMed ID: 3690239
    [No Abstract]   [Full Text] [Related]  

  • 5. The control of human pancreatic adenocarcinoma xenografts in nude mice by hormone therapy.
    Greenway B; Duke D; Pym B; Iqbal MJ; Johnson PJ; Williams R
    Br J Surg; 1982 Oct; 69(10):595-7. PubMed ID: 7127040
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of pancreatic cancer: current limitations, future possibilities.
    Blackstock AW; Cox AD; Tepper JE
    Oncology (Williston Park); 1996 Mar; 10(3):301-7; discussion: 308-23. PubMed ID: 8820445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebound effect after somatostatin treatment in Verner-Morrison syndrome.
    Bonfils S; René E; Pignal F; Rambaud JC
    Lancet; 1979 Sep; 2(8140):476. PubMed ID: 89540
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of pancreatic adenocarcinoma: a European perspective.
    Gouma DJ; Busch OR; van Gulik TM
    Surg Oncol Clin N Am; 2008 Jul; 17(3):569-86, ix. PubMed ID: 18486884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma.
    Fisher WE; Muscarella P; Boros LG; Schirmer WJ
    Int J Pancreatol; 1998 Dec; 24(3):169-80. PubMed ID: 9873951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormones in chemotherapy for pancreatic cancer, chemoagents or carriers?
    Siu TO; Kwan WB
    In Vivo; 1989; 3(4):255-8. PubMed ID: 2519861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical results and indications for adjuvant measures in pancreatic cancer].
    Beger HG; Büchler MW; Friess H
    Chirurg; 1994 Apr; 65(4):246-52. PubMed ID: 7912665
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormonal manipulation of metastatic carcinoma of the breast.
    Opipari MI
    J Am Osteopath Assoc; 1971 Aug; 70(12):1362-5. PubMed ID: 5209215
    [No Abstract]   [Full Text] [Related]  

  • 13. [Somatostatin].
    Shurygin DIa; Kulagin KV
    Vestn Akad Med Nauk SSSR; 1978; (2):89-9. PubMed ID: 347817
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pancreatic carcinoma, sex hormones receptors and treatment with tamoxifen].
    Grunebaum E; Chaitchuk S; Shoenfeld Y
    Harefuah; 1991 Mar; 120(6):340-3. PubMed ID: 1879772
    [No Abstract]   [Full Text] [Related]  

  • 15. [Somatostatin--its practical use in diseases of the digestive tract].
    Paradowski L
    Wiad Lek; 1986 Mar; 39(5):330-4. PubMed ID: 2873690
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of advanced pancreatic cancer].
    Lersch C; Classen M
    Dtsch Med Wochenschr; 1990 Mar; 115(9):340-2. PubMed ID: 1689634
    [No Abstract]   [Full Text] [Related]  

  • 17. The effectiveness of administering a minimal dose of octreotide long-term prior to surgery for insulinoma: report of a case.
    Tanaka Y; Funahashi H; Imai T; Naruse T; Suzumura K; Oda Y
    Surg Today; 2000; 30(6):541-3. PubMed ID: 10883468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment strategy of neuroendocrine tumors].
    Ducreux M; Baudin E; Schlumberger M
    Rev Prat; 2002 Feb; 52(3):290-6. PubMed ID: 11925720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal treatment of unresectable pancreatic cancer with LHRH analogue (goserelin).
    Sperti C; Pasquali C; Catalini S; Cappellazzo F; Bonadimani B; Militello C; Pedrazzoli S
    Eur J Surg Oncol; 1992 Jun; 18(3):267-71. PubMed ID: 1535051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones.
    Redding TW; Schally AV
    Proc Natl Acad Sci U S A; 1984 Jan; 81(1):248-52. PubMed ID: 6141560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.